Lipocine Inc.
LPCNNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $12.00M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.40$12.37
- Volume (live)
- -
- Avg. volume (3M)
- 3.78M
Lipocine (LPCN) Stock Price & Financial Analysis
Lipocine Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.43 - $1.60 |
|---|---|
| 52-Week High | $12.37 |
| 52-Week Low | $1.40 |
| Open | $1.56 |
| Volume (last close) | 354.74K |
| Average Volume (3M) | 3.78M |
| Revenue (TTM) | 1.57M |
|---|---|
| Net Income (TTM) | -11.85M |
| Free Cash Flow (TTM) | -11.19M |
| EPS (TTM) | −$1.81 |
| Profit Margin | -755.13% |
| Operating Margin | -800.82% |
| Return on Equity (ROE) | -54.45% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 12.00M |
|---|---|
| Shares Outstanding | 8.22M |
| Price to Sales (P/S) | 7.64 |
| Price to Book (P/B) | 0.55 |
| EV/EBITDA | -0.59 |
| 50-Day MA | $2.08 |
|---|---|
| 200-Day MA | $4.20 |
| 1-Year Change | −47.67% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Lipocine at a Glance
As of the Oct 22, 2026 close, Lipocine (LPCN) has a market capitalization of $12.00M. The stock trades at 7.6× sales. Over the trailing twelve months it lost $11.85M on revenue of $1.57M and burned $11.19M of free cash flow. Revenue fell 62.7% year over year.
As of its latest reported balance sheet, it holds $4.98M in cash and securities against $0.00 of debt, a net cash position of $4.98M.
Lipocine does not currently pay a dividend.
The share price is down 47.7% over the past year. At $1.46 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $1.40 to $12.37, below its 200-day moving average of $4.20.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Lipocine
What is the current stock price for LPCN?
As of the Oct 22, 2026 close, LPCN stock trades at $1.46. The 52-week range is $1.40–$12.37, with a day range of $1.43–$1.60.
What is the P/E ratio for LPCN?
The P/E ratio (Price-to-Earnings) for LPCN is shown in the Key Statistics section. This valuation metric helps compare Lipocine Inc. to industry peers.
Does LPCN pay dividends?
Lipocine does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for LPCN?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for LPCN is Buy.
What is the market cap of LPCN?
As of the Oct 22, 2026 close, Lipocine's market capitalization is $12.0M, classifying it as a micro-cap company. Lipocine operates in the Healthcare sector within the Biotechnology industry.